Literature DB >> 4207621

Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide.

H Y Reynolds, R E Thompson, H B Devlin.   

Abstract

Immunization with Pseudomonas lipopolysaccharide induced both cellular and humoral immunity in rabbits, particularly in the respiratory tract after intranasal immunization. Either parenteral (i.m.) or intranasal immunization elicited an IgG antibody response in respiratory secretions, but only intranasal immunization produced secretory IgA antibody. Immunization by both routes stimulated serum IgM and IgG agglutinative antibodies. Because both methods of immunization produced skin test reactivity which had components of both Arthus and tuberculin-like reactions, cellular immunity was more readily assessed by the measurement of migration inhibitory factor (MIF) released from immune lymphocytes in respiratory and spleen cell suspensions after challenge with the lipopolysaccharide antigen. After intranasal vaccination, MIF activity was detected in the respiratory tract by direct assay; in contrast, i.m. immunized rabbits did not produce respiratory MIF. Both modes of immunization resulted in splenic MIF activity. However, lymphocytes were only capable of producing MIF for short periods after primary immunization had ended, apparently losing this function in about 2-3 wk. Therefore, it was concluded that cellular immunity by in vitro assay was transient after primary immunization with this Pseudomonas antigen in contrast to the more persistent humoral immunity. The biological significance of immune lymphocytes as part of the coordinated host defense of the lung needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4207621      PMCID: PMC302623          DOI: 10.1172/JCI107683

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Characteristics of nonbacteremic Pseudomonas pneumonia.

Authors:  J R Tillotson; A M Lerner
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

2.  Escherichia coli pneumonia. Case report.

Authors:  P F Salomon; T T Tamlyn; M H Grieco
Journal:  Am Rev Respir Dis       Date:  1970-08

Review 3.  Typhoid fever: pathogenesis and immunologic control. 2.

Authors:  R B Hornick; S E Greisman; T E Woodward; H L DuPont; A T Dawkins; M J Snyder
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

4.  Characteristics of pneumonias caused by Escherichia coli.

Authors:  J R Tillotson; A M Lerner
Journal:  N Engl J Med       Date:  1967-07-20       Impact factor: 91.245

5.  New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

Authors:  M W Fisher; H B Devlin; F J Gnabasik
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

6.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

7.  Migratory response of granulomatous alveolar cells from BCG-sensitized rabbits.

Authors:  B Galindo; Q N Myrvik
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

8.  Cell-mediated immunity shown by lymphocytes from the respiratory tract.

Authors:  C S Henney; R H Waldman
Journal:  Science       Date:  1970-08-14       Impact factor: 47.728

9.  Activation of normal rabbit macrophage monolayers by supernatants of antigen-stimulated lymphocytes.

Authors:  J J Mooney; B H Waksman
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

10.  Immunochemical studies on equine antibodies to human gamma-2-globulin.

Authors:  P Z Allen; S Sirisinha; J H Vaughan
Journal:  J Immunol       Date:  1965-11       Impact factor: 5.422

View more
  9 in total

1.  Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms.

Authors:  G J Jakab
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

2.  Delayed homograft rejection following common bile duct ligation: in vivo evidence that obstructive jaundice is immunosuppressive.

Authors:  R M Keane; P B Collins; A H Johnson; D Bouchier Hayes
Journal:  Ir J Med Sci       Date:  1986-05       Impact factor: 1.568

3.  Depressed immune response in burn patients: use of monoclonal antibodies and functional assays to define the role of suppressor cells.

Authors:  A J McIrvine; J B O'Mahony; I Saporoschetz; J A Mannick
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

4.  Reaginic antibody production to protein antigens of Escherichia coli and Pseudomonas aeruginosa by mice.

Authors:  P J Danneman; J G Michael
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

5.  Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

Authors:  H Y Reynolds; J A Kazmierowski; H H Newball
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

6.  Appearance of specific antibody-bearing cells in human bronchial mucosa after local immunization with bacterial vaccine.

Authors:  F Latil; D Vervloet; P Casanova; L Garbe; P Fuentes; N Wierzbicki; J Charpin
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

7.  Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages.

Authors:  M Pollack; S E Anderson
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant.

Authors:  D O Sordelli; M C Cerquetti; A M Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  The carbohydrates associated with the surfaces of hamster alveolar macrophages: a study using fluorescein-conjugated lectins.

Authors:  C Meban
Journal:  J Anat       Date:  1985-03       Impact factor: 2.610

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.